These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23646045)

  • 1. Intracoronary adenosine to prevent myonecrosis in patients with stable angina undergoing percutaneous interventions: a double-blinded randomized controlled trial.
    Sanati HR; Ghanavati R; Zahedmehr A; Shakerian F; Bakhshandeh H; Firouzi A; Kiani R
    J Tehran Heart Cent; 2013 Jan; 8(1):28-34. PubMed ID: 23646045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention.
    Kizilirmak F; Gunes HM; Demir GG; Gokdeniz T; Guler E; Cakal B; Omaygenç MO; Yılmaz F; Savur U; Barutcu I
    Cardiovasc Drugs Ther; 2015 Dec; 29(6):519-526. PubMed ID: 26631392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial).
    De Luca G; Iorio S; Venegoni L; Marino P
    Am J Cardiol; 2012 Jan; 109(2):202-7. PubMed ID: 22000773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention.
    Arora S; Alfayoumi F; Khawaja AT; Dua A; Srinivasan V; Gradman AH
    Clin Cardiol; 2009 Jun; 32(6):315-20. PubMed ID: 19569065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study.
    Lee CH; Low A; Tai BC; Co M; Chan MY; Lim J; Lim YT; Tan HC
    Eur Heart J; 2007 Jan; 28(1):19-25. PubMed ID: 17132650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    Minerva Cardioangiol; 2014 Dec; 62(6):461-71. PubMed ID: 24699551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
    Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
    Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention.
    Kim BK; Oh SJ; Yoon SJ; Jeon DW; Ko YG; Yang JY
    Yonsei Med J; 2011 Sep; 52(5):717-26. PubMed ID: 21786434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
    Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y
    BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of index of microcirculatory resistance for early prediction of periprocedural myocardial microcirculatory injury after percutaneous coronary intervention in patients with coronary heart disease].
    You W; Yang ZJ; Ye F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):894-900. PubMed ID: 31744279
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
    Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.